The relationship between the exposure to PBDEs and PD is justified by the ability of these chemicals, at micromolar concentrations, to determine: high oxidative stress, impairment of calcium-dependent pathways, and inhibition of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) function. Here, SLC18A2 is linked to Parkinson disease.